Company intelligence / Profile preview

Garmen Laboratories

Montreal, Quebec, Canada

Ownership: Private
Employees: ~45
Development stage: Other

Overview

Garmen Laboratories was a privately held Canadian GMP-certified CMO/CRO specializing in pharmaceutical manufacturing and analytical testing for pharma, nutraceutical, and food industries. It was acquired in August 2013 by Advanomics Corporation to produce GMP material for Adva-27a, an anticancer small molecule targeting multidrug resistant cancers, including breast cancer, which was in IND-enabling stage for Phase 1. The facility was 50,000 sq ft, FDA-registered, and Health Canada-accredited. It was profitable prior to its acquisition.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Garmen Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Garmen Laboratories.

Explore the full profile